Mitochondria and Microbiota in Dialogue: The EVs Bridge

November 12-13, 2026 - Porto, Portugal

Welcome to the Third World Congress on Targeting Extracellular Vesicles 2026

It is with great pleasure that we welcome you to Targeting Extracellular Vesicles 2026, to be held on November 12–13, 2026 in Porto, Portugal.
Following the strong scientific momentum of previous editions, the spirit of Targeting EVs continues: to explore extracellular vesicles not as isolated entities, but as central drivers of biological communication, adaptation, and dynamic medicine. Read More

Targeting EV's 2026 Agenda

EXTRACELLULAR VESICLES: Bridging Mitochondria, Microbiota and Precision medicine

Call for Abstracts & Projects

Targeting EV's 2026 Confirmed Speakers

Glial EVs as Guardians of Axonal Mitochondria: Linking Neurobiology, Stress, and Inflammaging

Eva-Maria Krämer-Albers, Johannes Gutenberg University of Mainz, Germany

Bacterial Membrane Vesicles as Carriers of Bioactive Compounds

Leo Eberl, University of Zurich, Switzerland

Senescence Modulation Through EVs

Lino Ferreira, CNC-UC, University of Coimbra, Portugal

Bacterial Extracellular Vesicles Restore Immune Balance in Gut-First Parkinson’s Disease

Sandra Morais Cardoso, CNC-UC, University of Coimbra, Portugal

Redox Regulation of Extracellular Vesicle Communication

Carla Lopes, University of Minho, Portugal

Extracellular Vesicles in Cardiometabolic Medicine: Biomarkers, Mechanisms, and Therapies

Ramaroson Andriantsitohaina, Université de Montpellier, France

Hybrid EV-Based Platforms for Retinal mRNA Delivery

Elita Montanari, Università degli studi Roma Tre, Italy

Surface Functionalization and Tissue Tropism

Kuldeep Neote, Diadem Biotherapeutics, USA

GMP Manufacturing and Scalability Solutions in your Advertisement Materials

Andreia M. Silva, Exogenus Therapeutics, S.A., Portugal

Mitochondrial Signaling Beyond the Organelle: EVs-Mediated Neuroinflammation in Brain Injury

Bartosz Szczesny, The University of Texas Medical Branch, USA

Clinical Potential of MSC-EVs and Translational Challenges

Bernd Giebel, University Hospital Essen, Germany

Who is Attending Targeting Extracellular Vesicles 2026

Augusta University, USA
BIOCODEX, France
Biotechnology Research Center, Algeria
Diadem Biotherapeutics, USA
Exogenus Therapeutics, S.A., Portugal
IHMT – NOVA, Portugal
Johannes Gutenberg University of Mainz, Germany
Medical University of Gdańsk, Poland
Midwestern University, USA
New York University Grossman School of Medicine, USA
Orthopedic Associates of Long Island, United States
Oslo Metropolitan University, Norway
Shree Shodashi Therapeutics Private Limited, India
Symrise Srl, Italy
Thiogenesis Therapeutics, France
Umeå University, Sweden
Université de Moncton, Canada
Università degli Studi Roma Tre, Italy
University of Coimbra, Portugal
University of Groningen, Netherlands
University of Innsbruck, Austria
University of Liege, Belgium
University of Minho, Portugal
University of Montpellier, France
University of Namur, Belgium
University of Nebraska Medical Center, USA
University of Oulu, Finland
University of Oxford, UK
University of Paris, Portugal
University of Porto, Portugal
University of Texas Medical Branch, USA
University of Valencia, Spain
University of Zurich, Switzerland
Utrecht University, Netherlands

Updated till 16th July, 2026…

What's New

Scientific News

Targeting EVs Press

Follow Us

Subscribe to our Newsletter

Upcoming Events